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Abstract
Objectives: Autism is a developmental disorder characterized by social and emotional deficits, language
impairments and stereotyped behaviors that manifest in early postnatal life. This study aims to clarify the
relationship amongst absolute and relative concentrations of K
+,N a
+,C a
2+,M g
2+ and/or proinflammatory and
proapoptotic biomarkers.
Materials and methods: Na
+,K
+,C a
2+,M g
2+,N a
+/K
+,C a
2+/Mg
2+ together with IL6, TNFa as proinflammatory
cytokines and caspase3 as proapoptotic biomarker were determined in plasma of 25 Saudi autistic male patients
and compared to 16 age and gender matching control samples.
Results: The obtained data recorded that Saudi autistic patients have a remarkable lower plasma caspase3, IL6,
TNFa,C a
2+ and a significantly higher K
+ compared to age and gender matching controls. On the other hand both
Mg
2+ and Na
+ were non-significantly altered in autistic patients. Pearson correlations revealed that plasma
concentrations of the measured cytokines and caspase-3 were positively correlated with Ca
2+ and Ca
2+/K
+ ratio.
Reciever Operating Characteristics (ROC) analysis proved that the measured parameters recorded satisfactory levels
of specificity and sensitivity.
Conclusion: Alteration of the selected measured ions confirms that oxidative stress and defective mitochondrial
energy production could be contributed in the pathogenesis of autism. Moreover, it highlights the relationship
between the measured ions, IL6, TNFa and caspase3 as a set of signalling pathways that might have a role in
generating this increasingly prevalent disorder. The role of ions in the possible proinflammation and proapoptic
mechanisms of autistics’ brains were hypothesized and explained.
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Introduction
Children with Autism Spectrum Disorders (ASD) have
impairments in three core domains: socialization, commu-
nication, and restricted interests and repetitive behaviors
[1-4]. Researchers have reported that psychiatric comor-
bidity in ASD ranges from 41% to 70% [5,6].
Although the etiology of the disorder is unknown,
recent studies have suggested that the susceptibility to
autism is clearly attributable to genetic factors [7,8]. In
addition, emerging evidence points to inflammatory and
apoptotic mechanisms being responsible for certain neu-
ropsychiatric disorders including autism. Vargas et al. [9]
suggested neuroinflammatory processes are present in
the autistic brain by showing that transforming growth
factor (TGF)a1, macrophage chemoattractant protein
(MCP) 1, interleukin (IL)6 and IL10 are increased in the
brain of autistic subjects. A number of studies have also
shown that inflammatory cytokines including tumor
necrosis factor (TNF)a, interferon (IFN)a,I L 1 a,I L 6 ,I L 8
and IL12 are elevated in blood mononuclear cells, serum,
plasma and cerebrospinal fluid (CSF) of autistic subjects
[9-16].
The mechanisms of apoptosis induction are complex
and not fully known, but some key events are identified
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role of specific ions in the apoptotic process is slowly
being revealed. Changes in intracellular Ca
2+ have long
been associated with apoptotic neuronal cell death. Ca
2+
ionophores have been shown to induce ultrastructural
changes, such as cell shrinkage, chromatin condensation,
and DNA fragmentation, consistent with apoptosis
[17-20]. Increased Ca
2+ has been linked to processes
occurring during apoptosis including caspase activation.
One key event in apoptosis is loss of intracellular potas-
sium ions (K
+). Depletion of K
+ is necessary for cells to
shrink, activate caspases and degrade DNA [21-23], events
that in turn lead to further characteristic apoptotic changes
such as membrane blebbing and formation of apoptotic
bodies. Apoptosis due to forced loss of intracellular K
+ can
be induced by ionophores or K
+ channel activators [24-26].
In addition, Yu et al. [25,27] have also shown that the out-
ward K
+ current that ensues from N-methyl-D-aspartate
receptor activation has also been shown to induce apopto-
tic changes in cultured hippocampal neurons.
Just as with increased Ca
2+and K
+ efflux, the importance
of sodium (Na
+) entry in inducing neuronal injury and
death in response to pathophysiologic conditions, such as
hypoxia, has been well established [28-34]. Moreover,
B a n a s i a ke ta l .[ 3 5 ]p r o v e dt h a tb l o c k i n gN a
+ entry in
hypoxia-exposed neurons reduced the proportion of DNA
fragmentation and reduced apoptotic cell.
Magnesium (Mg
2+) has a profound effect on neural
excitability; the most characteristic signs and symptoms of
Mg
2+ deficiency are produced by neural and neuromuscu-
lar hyperexcitability [36]. Iotti and Malucelli [37] clarify
the functional relationship between energy metabolism
and free [Mg
2+], providing evidence that brain cells cyto-
solic [Mg
2+] is regulated to equilibrate any changes in
rapidly available free energy. Moreover, it has also been
shown that the measurement of brain Mg
2+ can help in
the differential diagnosis of neurodegenerative diseases
sharing common clinical features.
The immune system has been postulated to play an
important role in the etiology of autism. Investigators have
proposed infectious, autoimmune, and cytokine-related
etiologies.
These information initiate our interest to measure con-
centrations of Na
+,K
+,C a
2+,M g
2+ together with caspase3
as a proapoptotic marker, IL6 and TNFa as proinflamma-
tion markers in the plasma of autistic patients from Saudi
Arabia in an attempt to understand the role and relation-
ship of these biochemical parameters in the etiology of
autism and its commonly related psychiatric conditions.
Material and methods
Subjects and methods
The study protocol followed the ethical guidelines of the
most recent Declaration of Helsinki (Edinburgh, 2000). All
subjects enrolled in the study (25 autistic male patients
and 16 age and gender matched controls) had written
informed consent provided by their parents and assented
to participate if developmentally able. They were enrolled
through the ART Center (Autism Research & Treatment
Center) clinic (Riyadh, Saudi Arabia). The ART Center
clinic sample population consisted of children diagnosed
on the ASD. The diagnosis of ASD was confirmed in all
subjects using the Autism Diagnostic Interview-Revised
(ADI-R) and the Autism Diagnostic Observation Schedule
(ADOS) and 3DI (Developmental, dimensional diagnostic
interview). The ages of all autistic children who partici-
pated were between the ages of 4 and 12 years old. All
were simplex cases. All are negative for fragile × gene
study. The control group recruited from Well baby Clinic
at King Khaled University hospital with mean age 4-11
year old. Subjects were excluded from the investigation if
they had organic aciduria, dysmorphic features, or diagno-
sis of Fragile × or other serious neurological (e.g., sei-
zures), psychiatric (e.g., bipolar disorder) or known
medical conditions. All participants were screened via par-
ental interview for current and past physical illness. Chil-
dren with known endocrine, cardiovascular, pulmonary,
liver, kidney or other medical disease were excluded from
the study. None of the recruited autistic patients were on
special diets or alternative treatments.
Ethics approval and consent
A written consent was obtained from the parents of each
individual case, according to the guidelines of the ethical
committee of King Khalid Hospital, King Saud University.
Blood samples
After overnight fast, 10 ml blood samples were collected
from both groups in test tubes containing sodium
heparin as anticoagulant. Tubes were centrifuged at 3500
rpm at room temperature for 15 minutes, plasma was
obtained and deep freezed (at -80°C) until analysis time.
Measurement of calcium
The UDI (United Diagnostics Industry, Saudi Arabia) Ca
2
+ procedure is based on the reaction of Ocresolphthalein
complexone (O-CPC) with Ca
2+ to form a chromogenic
complex that absorbs light which is measured photome-
trically at 575 nm. Mg
2+ interference is prevented by
sequestration with 8-hydroxyquinoline. 2-Ethylami-
noethanol is used to establish the reaction pH at 12.
Dimethyl sulfoxide is used to lower the dielectric con-
stant of the reaction mixture and to repress the ioniza-
tion of cresolphthalein complexone [38].
Measurement of potassium
K
+ reacts with sodium tetra phenyl boron in a protein
free alkaline medium to produce a colloidal suspension
El-Ansary et al. Journal of Neuroinflammation 2011, 8:142
http://www.jneuroinflammation.com/content/8/1/142
Page 2 of 9[39]. The turbidity which is proportional to the K
+ con-
centration in the range of 2-7 mmol/L was measured
against blank. The concentration was calculated using a
typically treated standard solution of K
+ chloride in
Bovine albumin equivalent to 4 mol/L.
Measurement of sodium
Plasma Na
+ was measured according to the method of
Tietz [40] using a diagnostic kit, a product of UDI in which
Na
+ was determined via Na+ dependent b-galactosidase
activity using O-nitrophenyl-b, D-galactopyranoside.
Measurement of magnesium
The UDI method stems from the original work of Lind-
strom and Diehl [41] using calmagite, 1-(1-hydroxy-4-
methyl-2- phenylazo)-2-naphthol-4-sulfonic acid, as the
complexometric reagent. Ca
2+ is masked by sequestration
with strontium ethylene-bis-(oxyethylenenitrilo)-tetra
acetate (EGTA Sr) [42]. A surfactant system has been uti-
lized to overcome protein interference. Mg
2+ form a
colored complex with calmagite in alkaline medium to
produce a red complex that absorbs light which is mea-
sured spectrophotometrically at 530 nm. The absorbance
of the red complex is directly proportional to the concen-
tration of Mg
2+ in the sample.
Statistical analysis
A SPSS (Statistical Package for the Social Sciences) com-
puter program was used. Results were expressed as mean
± S.D. and all statistical comparisons were made by
means of independent t-test with P ≤ 0.05 was considered
significant. ROC analysis was performed. Area under the
curve, cutoff values together with degree of specificity
and sensitivity were calculated.
Results
T a b l e1a n dF i g u r e1d e m o n s t r a t ec o n c e n t r a t i o n so ft h e
measured parameters in plasma of autistic patients com-
pared to control. Concentrations of caspase3, IL6 and
TNFa were significantly lower in children with autism
compared to control. In contrast, K
+ was significantly
raised in plasma samples from children with autism com-
pared to age and gender matching controls recording 2.3
fold higher values. In addition, Ca
2+,C a
2+/Mg
2+ and Na
+/
K
+ ratio were significantly lower in autistic compared to
control with the latter showing almost 3 fold lower values.
Figure 2 shows the percentage changes of the measured
parameters in autistics relative to control subjects. It could
be easily seen that caspase3, IL6 and TNFa recorded more
or less the average % decrease with values of -27.5,-20.2
and -29.8. Among the measured elements K
+ recorded the
most remarkable percentage increase recording value of
130% higher concentration in autistic compared to control
with concomitant decrease in Na
+/K
+ ratio of 69.9%
decrease. Ca
2+/Mg
2+ ratio recorded 63.8% lower values in
control. Absolute values of Na
+ and Mg
2+ recorded the
lowest percentage changes recording 13.1% and 5.9%
increase, respectively. Table 2 and Figure 3 show the sig-
nificantly positive and negative correlated parameters. Out
of the 27 correlations recorded in table 3, the most signifi-
cantly correlated parameters were selected to be presented
in Figure 3. Table 3 together with Figure 4 show ROC ana-
lysis of the measured parameters. It could be easily noticed
that most of the measured parameters recorded satisfac-
tory values of sensitivity and specificity with the exception
of Mg
2+ and Na
+ which show low specificity values.
Discussion
Protection of the brain from injury during the fetal, neo-
natal and postnatal periods is of major importance
owing to the significant number of infants who now sur-
vive early brain injury but develop neurodevelopmental
and motor disabilities.
Table 1 and Figures 1 and 2 show the unexpected
lower concentrations of caspase3, TNFa and IL6. This
could be interpreted on the basis that the etiology of the
fetal brain damage inflammation will involve many
Table 1 Caspase3, IL6, TNFa,C a
2+,M g
2+,N a
+ and K
+
concentrations and Ca
2+/Mg
2+ and Na
+/K
+ ratios in
plasma of autistic patients (N = 25) compared to age and
gender matching controls (N = 16)
Parameters Groups Min. Max. Mean ± S.D. P value
Caspase3 (ng/ml) Control 135.54 189.47 170.17 ± 13.05 > 0.001
Autistic 81.94 158.28 123.40 ± 23.37
IL6
(pg/ml)
Control 303.18 394.41 343.34 ± 28.16
Autistic 225.42 347.41 273.95 ± 30.82
TNFa
(pg/ml)
Control 306.53 395.66 360.85 ± 29.05
Autistic 129.44 381.28 253.16 ± 64.07
Ca
2+
(mmol/L)
Control 9.49 14.77 12.29 ± 1.53
Autistic 3.17 6.85 4.42 ± 0.87
Mg
2+
(mmol/L)
Control 1.42 2.47 1.86 ± 0.35 0.411
Autistic 1.00 2.76 1.97 ± 0.43
Na
+
(mmol/L)
Control 76.20 139.92 120.92 ± 21.94 0.036
Autistic 65.18 123.69 105.06 ± 17.43
K
+
(mmol/L)
Control 1.20 7.90 4.76 ± 2.04 > 0.001
Autistic 3.60 22.30 10.95 ± 5.26
Ca
2+/Mg
2+ Control 5.01 8.41 6.74 ± 0.99
Autistic 1.40 6.82 2.44 ± 1.15
Na
+/K
+ Control 10.45 109.14 34.55 ± 26.01 0.004
Autistic 4.15 19.57 10.41 ± 4.73
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Figure 1 Mean with the standard error bars of measured Caspase3, IL6 and TNFa (a), Ca
2+,M g
2+ and Ca
2+/Mg
2+(b), and Na
+,K
+ and
Na
+/K
+(c) in autistic patients (N = 25) compared to age and gender matching controls (N = 16). Caspase3 concentration is expressed as
ng/mL plasma and IL6 and TNFa concentrations are expressed as pg/mL plasma. Na
+,K
+,M g
2+ and Ca
2+ concentrations are expressed in
mmol/L plasma.
 
 
 
 
 
Figure 2 Percentage change in caspase3, IL6, TNFa,C a
2+,M g
2+,N a
+,K
+,C a
2+/Mg
2+ and Na
+/K
+ of autistic patients (N = 25) compared
to age and gender matching controls (N = 16).
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cytokine concentrations. Rees et al. [43] have shown, for
example that TNFa [44] and IL6 concentrations [45]
increase within the early 6 hours of lipopolysaccharide
(LPS) exposure. It has been proposed that circulating
cytokines might act on cerebralendothelial cells or peri-
ventricular cells to upregulate prostaglandin synthesis,
resulting in increased permeability of the blood-brain
barrier [46]; thus the administration of LPS to fetal
sheep results in the extravasation of plasma proteins
and macrophages into the brain [46].
TNFa and IL6 are cytokines involved in cell-mediated
immune response and their production has been shown
to be associated with tissue inflammation and necrosis
[47]. Based on these information, the recorded lower
plasma concentrations of these two cytokines does not
oppose with the neuroinflammatory model recently
proved for autism [48]. This could help us to suggest that
localized inflammation of the central nervous system
may contribute to the pathogenesis of autism and that
elevation of plasma cytokines could be an early event fol-
lowed by infiltration of macrophages, cytokines and proa-
potic factors across the BBB to the brain. The lower
recorded concentration of caspase3 in autistics compared
to control subjects could be easily related to the decrease
in TNFa. This could be supported through considering
the previous report of Mundle et al. [49] which demon-
strated a link between TNFa and the major effectors of
its apoptotic signal, i.e. Caspase1 and 3. They identify the
downstream effectors of TNFa apoptotic signalling and
show a positive correlation of TNFa with Caspase3.
A major endogenous antioxidant in mammalian cells is
the enzyme superoxide dismutase (SOD), which catalyzes
the dismutation of the superoxide anion (O2
-)i n t o
hydrogen peroxide (H2O2) and molecular oxygen (O2).
Dimayuga et al. [50] show that overexpression of SOD1
in microglial cells leads to significant decreases in super-
oxide concentrations, with corresponding increases in
H2O2 concentrations. They proved that the release of the
proinflammatory cytokines TNFa and IL6 is significantly
attenuated by overexpression of SOD1. With special con-
sideration of the effect of population, the recorded lower
concentrations of TNFa and IL6 in autistic patients as
subjects of the present study compared to controls could
be related to the overexpression of SOD previously
reported as metabolic biomarker in Saudi autistic
patients [51].
Table 1 and Figure 2 demonstrate that autistic patients
from Saudi Arabia recorded lower concentrations of
plasma Ca
2+. This could find a support through consider-
ing the work of Shearer et al. [52] in which they observed
lower Ca
2+ concentrations in the hair of autistic popula-
tion and that of Krey and Dolmetsch [53] in which they
proved that some forms of autism are caused by failures
in activity-dependent regulation of neural development
due to mutations of several voltage-gated and ligand-
gated ion channels that regulate neuronal excitability and
Ca
2+ signalling. On the other hand, the recorded lower
concentration of Ca
2+ is not in accordance with the
recent work of Laura et al. (2011) [54] which reported
higher Ca
2+ concentrations in plasma of Italian autistic
patients compared to age and gender matching controls.
The reduced plasma Ca
2+ concentrations of the present
study could be associated with high intracellular brain
Ca
2+ in autistics compared to control subjects. This sug-
gestion could be supported with the recent evidence
from post-mortem studies of autistic brains which points
toward abnormalities in mitochondrial function as possi-
ble downstream consequences of dysreactive immunity
and altered Ca
2+ signalling [55]. Low plasma Ca
2+ and
the speculated high brain Ca
2+ concentration could be
easily correlated to the oxidative stress previously
Table 2 Pearson correlation test between the measured
parameters
Parameters R (Person Correlation) Sig.
Caspase3 ~ IL6 0.627 + > 0.01
Caspase3 ~ TNFa 0.598 +
Caspase3 ~ Ca
2+ 0.731 +
Caspase3 ~ Na
+ 0.486 +
Caspase3 ~ K+ -0.412 -
Caspase3 ~ Ca
2+/Mg
2+ 0.666 +
Caspase3 ~ Na
+/K
+ 0.459 +
IL6 ~ TNFa 0.469 +
IL6 ~ Ca
2+ 0.680 +
IL6 ~ Na
+ 0.505 +
IL6 ~ K
+ -0.423 -
IL6 ~ Ca
2+/Mg
2+ 0.691 +
IL6 ~ Na
+/K
+ 0.551 +
TNFa ~C a
2+ 0.633 +
TNFa ~C a
2+/Mg
2+ 0.521 +
Ca
2+ ~K
+ -0.582 -
Ca
2+ ~C a
2+/Mg
2+ 0.912 +
Ca
2+ ~N a
+/K
+ 0.503 +
Mg
2+ ~N a
+ -0.537 -
Mg
2+ ~C a
2+/Mg
2+ -0.476 -
Na
+ ~C a
2+/Mg
2+ 0.552 +
Na
+ ~N a
+/K
+ 0.526 +
Ca
2+/Mg
2+ ~N a
+/K
+ 0.592 +
K
+ ~C a
2+/Mg
2+ -0.604 -
K
+ ~N a
+/K
+ -0.650 -
Na
+ ~K
+ -0.363 - 0.049
Correlation is significant at the 0.01 level (2-tailed).
+Positive Correlation
-Negative Correlation
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Ca
2+ is recently related to ROS generation. Mitochondrial
aspartate/glutamate carrier (AGC1), isoform predomi-
nantly expressed in the brain, heart and skeletal muscle,
is known to play a pivotal role in energy metabolism and
is regulated by neurone intracellular Ca
2+[57,58]. This
carrier was found to be approximately three-fold higher
in brain homogenates from each of six autistic patients
compared to their matched controls. This could support
the lower plasma Ca
2+ concentrations recorded in the
present study. Moreover, direct fluorimetric measure-
ments of Ca
2+ concentrations in the post-mortem mito-
chondrial supernatant confirmed significantly higher Ca
2+
concentrations in brain of autistics [55].
This suggested increased influx of blood-to-brain Ca
2+
could be easily related to the loss of amyloid beta (Ab)
equilibrium between the brain and blood which may
lead to failure of drawing out Ab from the brain across
the blood brain barrier (BBB) as a mechanism for Ab
accumulation in Saudi autistics [Al-Ayahdi L, Ben Bacha
A, Kotb M, El-Ansary A: An o v e ls t u d yo na m y l o i db
peptide 40, 42 and 40/42 ratio in Saudi autistics,
Submitted]. Vitamin E which is known to attenuate A
b-induced apoptosis despite Ca
2+ accumulation in brain
cells is significantly lower in Saudi autistic patients [51].
This could support the suggested mechanism relating
Ab and Ca
2+- induced apoptosis in brain cells of Saudi
autistics.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Pearson correlations between the measured parameters with best fit line curve: (a) Caspase3 and IL6 (positive correlation); (b):
Caspase3 and TNFa (positive correlation); (c): Caspase3 and Ca
2+ (positive correlation); (d): Caspase3 and K
+ (negative correlation); (e): Caspase3
and Ca
2+/Mg
2+ (positive correlation); (f): IL6 and Ca
2+ (positive correlation); (g): IL6 and Ca
2+/Mg
2+ (positive correlation), (h): TNFa and Ca
2+
(positive correlation); (i):C a
2+ and K
+ (negative correlation).
Table 3 ROC analysis of Ca
2+/Mg
2+ and Na
+/K
+ ratios and Caspase3, IL6, TNFa,C a
2+,M g
2+,N a
+and K
+ in autistic
groups (N = 25)
Parameter Area under the curve Best Cutoff value Sensitivity % Specificity %
Caspase3 0.968 161.17 100.0% 86.7%
IL6 0.952 301.95 84.0% 100.0%
TNFa 0.915 297.67 76.0% 100.0%
Ca
2+ 1.000 8.17 100.0% 100.0%
Mg
2+ 0.592 1.76 97.2% 53.3%
Na
+ 0.786 124.50 100.0% 71.4%
K
+ 0.900 7.00 84.0% 85.7%
Ca
2+/Mg
2+ 0.981 4.41 95.8% 100.0%
Na
+/K
+ 0.888 17.14 93.8% 78.6%
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+ concentrations in
plasma of autistic and control subjects. It could be easily
noticed that autistic patients recorded raised concentra-
tions of K
+ compared to controls. This could be attributed
to the altered Na
+/K
+ ATPase activity previously reported
by El-Ansary et al. [56], which may represent an important
neurotoxic mechanism for neurons.
The recorded higher plasma concentrations of K
+
which reflect the remarkable higher rate of k
+ efflux from
brain to blood in autistic patients could be easily related
to the significant lower Ca
2+, the unchanged Na
+,l o w e r
Ca
2+/Na
+ ratios and to the speculated higher brain cas-
pase3 activity. Xiao et al. [59] showed previously that
activation of the N-methyl-D-aspartic acid (NMDA) sub-
type of glutamate receptors in a low Ca
2 and Na
+ condi-
tion induced apoptotic neuronal death, and that the K
+
efflux via NMDA receptor channels was likely a key
event in NMDA-induced apoptosis. This postulation
could be supported by Pigozzi et al. [60] who proved that
entry of Ca
2+ into neuron cells can accelerate apoptosis
by accelerating the expression of growth arrest and DNA
Damage inducible gene 153 (GADD153) and by inducing
a prolonged efflux of K
+ out of the cell. This is in good
agreement with the elevated K
+ and the reduced Ca
2+
concentrations in plasma of autistic patients compared to
controls as a report of the present study. Moreover, the
significantly impaired Ca
2+ and K
+ concentrations in
plasma of autistic patients could be easily related to the
postulated increase of brain cytokines (TNFa and IL6)
after infiltration from plasma to brain. Experimental evi-
dence demonstrates that ion channels are targeted by
cytokines, which can specifically modulate their function
[61] and TNFa was associated with the remarkable Ca
2+
influx from blood to brain [62]. These suggested mechan-
isms of the alteration of the studied parameters could be
supported through the obtained Pearson correlations
presented in table 3 and Figure 3.
ROC analysis presented in Figure 4, support the pre-
vious discussion and suggestions which based on the
obtained data. Most of the measured parameters recorded
AUC near 1 and satisfactory levels of specificity and sensi-
tivity and hence they could be used as biochemical mar-
kers for the early diagnosis of autism in Saudi population.
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Figure 4 ROC curves showing area under the curves, specificity and sensitivity of caspase3 (a), IL6 (b), TNFa (c), K
+(d) Ca
2+(e), Mg
2+(f),
Na
+(g) Ca
2+/Mg
2+(h) and Na
+/K
+(i) in autistic patients (N = 25).
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